Kyntra Bio, Inc. also files under FGEN; those filings are included.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 12, 2026 | Schoeneck James A | Director | Grant(A) | 7K | — | $0 |
| Jun 12, 2026 | Edwards Jeffrey L | Director | Grant(A) | 7K | — | $0 |
| Jun 12, 2026 | Ho Maykin | Director | Grant(A) | 7K | — | $0 |
| Jun 12, 2026 | Kauffman Michael | Director | Grant(A) | 7K | — | $0 |
| Jun 6, 2026 | DeLucia David | Chief Financial Officer | Tax withholding(F) | 52 | $6.71 | $349 |
| Jun 6, 2026 | Wettig Thane | CEO, Director | Tax withholding(F) | 198 | $6.71 | $1K |
| May 14, 2026 | Wettig Thane | CEO, Director | Buy(P) | 3K | $7.09 | $20K |
| Mar 6, 2026 | DeLucia David | Chief Financial Officer | Tax withholding(F) | 60 | $6.84 | $410 |
| Mar 6, 2026 | Wettig Thane | CEO, Director | Tax withholding(F) | 277 | $6.84 | $2K |
| Feb 3, 2026 | Wettig Thane | CEO, Director | Grant(A) | 60K | — | $0 |
| Feb 3, 2026 | DeLucia David | Chief Financial Officer | Grant(A) | 26K | — | $0 |
| Dec 6, 2025 | Wettig Thane | CEO, Director | Tax withholding(F) | 259 | $8.42 | $2K |
| Dec 6, 2025 | DeLucia David | Chief Financial Officer | Tax withholding(F) | 52 | $8.42 | $438 |
| Nov 17, 2025 | Wettig Thane | CEO, Director | Buy(P) | 3K | $9.10 | $25K |
| Nov 13, 2025 | Wettig Thane | CEO, Director | Buy(P) | 1K | $9.18 | $9K |
| Sep 6, 2025 | Wettig Thane | CEO, Director | Tax withholding(F) | 248 | $12.10 | $3K |
| Sep 6, 2025 | DeLucia David | Chief Financial Officer | Tax withholding(F) | 53 | $12.10 | $641 |
| Jun 30, 2025 | Schoeneck James A | Director | Buy(P) | 24K | $5.07 | $119K |
| Jun 6, 2025 | DeLucia David | Chief Financial Officer | Tax withholding(F) | 51 | $7.83 | $399 |
| Jun 6, 2025 | Wettig Thane | CEO, Director | Tax withholding(F) | 246 | $7.83 | $2K |
| Jun 4, 2025 | Kauffman Michael | Director | Grant(A) | 70K | — | $0 |
| Jun 4, 2025 | Kauffman Michael | Director | Grant(A) | 120K | — | $0 |
| Jun 4, 2025 | Ho Maykin | Director | Grant(A) | 120K | — | $0 |
| Jun 4, 2025 | Edwards Jeffrey L | Director | Grant(A) | 120K | — | $0 |
| Jun 4, 2025 | Schoeneck James A | Director | Grant(A) | 120K | — | $0 |
| Mar 24, 2025 | Wettig Thane | CEO, Director | Buy(P) | 145K | $0.35 | $51K |
| Mar 21, 2025 | Schoeneck James A | Director | Buy(P) | 50K | $0.34 | $17K |
| Mar 20, 2025 | Schoeneck James A | Director | Buy(P) | 250K | $0.35 | $88K |
| Mar 6, 2025 | Wettig Thane | CEO, Director | Tax withholding(F) | 367 | $0.39 | $143 |
| Mar 6, 2025 | Wettig Thane | CEO, Director | Grant(A) | 781 | — | $0 |
| Mar 6, 2025 | Chung Christine | SVP, CHINA OPERATIONS | Tax withholding(F) | 7K | $0.39 | $3K |
| Mar 6, 2025 | Chung Christine | SVP, CHINA OPERATIONS | Grant(A) | 781 | — | $0 |
| Mar 6, 2025 | Wettig Thane | CEO, Director | Tax withholding(F) | 22K | $0.39 | $9K |
| Mar 6, 2025 | Chung Christine | SVP, CHINA OPERATIONS | Tax withholding(F) | 422 | $0.39 | $165 |
| Mar 6, 2025 | DeLucia David | Chief Financial Officer | Tax withholding(F) | 2K | $0.39 | $907 |
| Jan 9, 2025 | DeLucia David | Chief Financial Officer | Grant(A) | 525K | — | $0 |
| Jan 9, 2025 | Wettig Thane | CEO, Director | Grant(A) | 1.3M | — | $0 |
| Dec 7, 2024 | Graham Juan | CHIEF FINANCIAL OFFICER | Tax withholding(F) | 1K | $0.34 | $362 |
| Dec 6, 2024 | Wettig Thane | CEO, Director | Tax withholding(F) | 2K | $0.34 | $803 |
| Dec 6, 2024 | Chung Christine | SVP, CHINA OPERATIONS | Tax withholding(F) | 3K | $0.34 | $949 |
| Dec 6, 2024 | Graham Juan | CHIEF FINANCIAL OFFICER | Tax withholding(F) | 1K | $0.34 | $492 |
| Sep 7, 2024 | Graham Juan | CHIEF FINANCIAL OFFICER | Tax withholding(F) | 1K | $0.39 | $415 |
| Sep 6, 2024 | Wettig Thane | CEO, Director | Tax withholding(F) | 2K | $0.39 | $922 |
| Sep 6, 2024 | Graham Juan | CHIEF FINANCIAL OFFICER | Tax withholding(F) | 16K | $0.39 | $6K |
| Sep 6, 2024 | Chung Christine | SVP, CHINA OPERATIONS | Tax withholding(F) | 17K | $0.39 | $7K |
| Aug 1, 2024 | Wettig Thane | CEO, Director | Tax withholding(F) | 21K | $0.47 | $10K |
| Jun 22, 2024 | Wettig Thane | CEO, Director | Tax withholding(F) | 782 | $1.13 | $884 |
| Jun 12, 2024 | Adib Deyaa | Chief Medical Officer | Buy(P) | 22K | $1.17 | $26K |
| Jun 7, 2024 | Graham Juan | CHIEF FINANCIAL OFFICER | Tax withholding(F) | 1K | $1.10 | $1K |
| Jun 6, 2024 | Graham Juan | CHIEF FINANCIAL OFFICER | Tax withholding(F) | 18K | $1.19 | $21K |
| Jun 6, 2024 | Chung Christine | SVP, CHINA OPERATIONS | Tax withholding(F) | 19K | $1.19 | $23K |
| Jun 6, 2024 | Wettig Thane | CEO, Director | Tax withholding(F) | 2K | $1.19 | $3K |
| Jun 5, 2024 | Cravatt Benjamin | Director | Grant(A) | 70K | — | $0 |
| Jun 5, 2024 | Schoeneck James A | Director | Grant(A) | 70K | — | $0 |
| Jun 5, 2024 | Ho Maykin | Director | Grant(A) | 70K | — | $0 |
| Jun 5, 2024 | Brennan Aoife | Director | Grant(A) | 70K | — | $0 |
| Jun 5, 2024 | Edwards Jeffrey L | Director | Grant(A) | 70K | — | $0 |
| Jun 5, 2024 | Blaug Suzanne | Director | Grant(A) | 70K | — | $0 |
| Jun 5, 2024 | Lema Gerald | Director | Grant(A) | 70K | — | $0 |
| May 1, 2024 | Wettig Thane | CEO, Director | Tax withholding(F) | 21K | $1.17 | $24K |
| Mar 22, 2024 | Wettig Thane | CEO, Director | Tax withholding(F) | 782 | $2.58 | $2K |
| Mar 7, 2024 | Graham Juan | CHIEF FINANCIAL OFFICER | Tax withholding(F) | 1K | $1.79 | $2K |
| Mar 7, 2024 | Wettig Thane | CEO | Buy(P) | 50K | $1.91 | $96K |
| Mar 6, 2024 | Graham Juan | CHIEF FINANCIAL OFFICER | Tax withholding(F) | 20K | $1.87 | $38K |
| Mar 6, 2024 | Graham Juan | CHIEF FINANCIAL OFFICER | Grant(A) | 781 | — | $0 |
| Mar 6, 2024 | Graham Juan | CHIEF FINANCIAL OFFICER | Tax withholding(F) | 422 | $1.87 | $789 |
| Mar 6, 2024 | Wettig Thane | CEO | Tax withholding(F) | 4K | $1.87 | $8K |
| Mar 6, 2024 | Wettig Thane | CEO | Grant(A) | 781 | — | $0 |
| Mar 6, 2024 | Wettig Thane | CEO | Tax withholding(F) | 326 | $1.87 | $610 |
| Mar 6, 2024 | Chung Christine | SVP, CHINA OPERATIONS | Tax withholding(F) | 422 | $1.87 | $789 |
| Mar 6, 2024 | Chung Christine | SVP, CHINA OPERATIONS | Tax withholding(F) | 23K | $1.87 | $43K |
| Mar 6, 2024 | Chung Christine | SVP, CHINA OPERATIONS | Grant(A) | 781 | — | $0 |
| Feb 21, 2024 | Graham Juan | CHIEF FINANCIAL OFFICER | Grant(A) | 260K | — | $0 |
| Feb 21, 2024 | Graham Juan | CHIEF FINANCIAL OFFICER | Grant(A) | 52K | — | $0 |
| Feb 21, 2024 | Chung Christine | SVP, CHINA OPERATIONS | Grant(A) | 29K | — | $0 |
| Feb 21, 2024 | Wettig Thane | CEO | Grant(A) | 834K | — | $0 |
| Feb 21, 2024 | Wettig Thane | CEO | Grant(A) | 166K | — | $0 |
| Feb 21, 2024 | Chung Christine | SVP, CHINA OPERATIONS | Grant(A) | 143K | — | $0 |
| Feb 1, 2024 | Wettig Thane | CEO | Tax withholding(F) | 23K | $2.37 | $56K |
| Dec 22, 2023 | Wettig Thane | CEO | Tax withholding(F) | 819 | $0.76 | $622 |
| Dec 7, 2023 | Graham Juan | Chief Financial Officer | Tax withholding(F) | 1K | $0.62 | $673 |
| Dec 6, 2023 | Graham Juan | Chief Financial Officer | Tax withholding(F) | 16K | $0.58 | $9K |
| Dec 6, 2023 | Wettig Thane | CEO | Tax withholding(F) | 2K | $0.58 | $974 |
| Dec 6, 2023 | Chung Christine | SVP, China Operations | Tax withholding(F) | 18K | $0.58 | $11K |
| Nov 1, 2023 | Wettig Thane | CEO | Tax withholding(F) | 22K | $0.55 | $12K |
| Sep 22, 2023 | Wettig Thane | Interim CEO | Tax withholding(F) | 819 | $0.79 | $647 |
| Sep 7, 2023 | Graham Juan | Chief Financial Officer | Tax withholding(F) | 1K | $0.99 | $1K |
| Sep 6, 2023 | Eisner Mark | EVP, Chief Medical Officer | Tax withholding(F) | 2K | $0.96 | $2K |
| Sep 6, 2023 | Chung Christine | SVP, China Operations | Tax withholding(F) | 3K | $0.96 | $3K |
| Sep 6, 2023 | Wettig Thane | Interim CEO | Tax withholding(F) | 2K | $0.96 | $2K |
| Sep 6, 2023 | Graham Juan | Chief Financial Officer | Tax withholding(F) | 711 | $0.96 | $683 |
| Sep 1, 2023 | Eisner Mark | EVP, Chief Medical Officer | Tax withholding(F) | 1K | $1.06 | $1K |
| Sep 1, 2023 | Henderson Jeffrey William | Director | Sell(S) | 2K | $1.03 | $2K |
| Aug 30, 2023 | Graham Juan | Chief Financial Officer | Grant(A) | 220K | — | $0 |
| Aug 30, 2023 | Graham Juan | Chief Financial Officer | Grant(A) | 120K | — | $0 |
| Aug 30, 2023 | Chung Christine | SVP, China Operations | Grant(A) | 220K | — | $0 |
| Aug 30, 2023 | Chung Christine | SVP, China Operations | Grant(A) | 120K | — | $0 |
| Aug 10, 2023 | Schoeneck James A | Director | Grant(A) | 10K | — | $0 |
| Aug 7, 2023 | Wettig Thane | Chief Commercial Officer | Grant(A) | 300K | — | $0 |
| Aug 7, 2023 | Wettig Thane | Chief Commercial Officer | Grant(A) | 200K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Kyntra Bio, Inc., SEC CIK 0000921299. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under KYNB and shows every filing by that issuer (also filed as FGEN).
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-05. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for KYNB